Evaluating a Therapeutic Education Program for Patients with Central Venous Access
Adherence to and Understanding of a Therapeutic Education Program for Patients With Central Venous Lines
This study is testing a new educational program, including a mobile app, to help patients with PICC lines better understand their care and stay safe while using these devices.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 1 site (Bobigny) |
| Trial ID | NCT06478849 on ClinicalTrials.gov |
What this trial studies
This project aims to assess adherence and understanding of a therapeutic education program for patients with peripherally inserted central catheters (PICC lines). By equipping patients with knowledge and skills related to their invasive devices, the study seeks to empower them in their own care and reduce associated risks. The program includes the development of a mobile application for education and monitoring, and it will evaluate communication tools and messages validated by experts. The study will involve a prospective cohort of patients to gather data on their experiences and understanding.
Who should consider this trial
Good fit: Ideal candidates are adult patients over 18 years old who require a PICC line and have access to communication tools with internet connectivity.
Not a fit: Patients who do not understand French or are under legal protection may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly enhance patient safety and reduce complications associated with central venous access.
How similar studies have performed: While this approach is innovative, similar educational interventions have shown promise in improving patient outcomes in other settings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adult patients over 18 years of age 2. Patients requiring a PICC line 3. Patients with a means of communication with an Internet connection (computer or cell phone) or an alternative solution (landline telephone) 4. Patients with a predicted life expectancy of more than 6 weeks Exclusion Criteria: 1. Patient opposed to participating in the study 2. Patient does not understand French 3. Patient not affiliated to a French social security scheme 4. Patient under guardianship or curatorship 5. Patient under court protection
Where this trial is running
Bobigny
- Hopital Avicenne — Bobigny, France (Recruiting)
Study contacts
- Principal investigator: Camille Reinprecht — Hopital AVICENNE
- Study coordinator: Camille REINPRECHT
- Email: camille.reinprecht@aphp.fr
- Phone: 01.48.95.53.32
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.